The North America Pain Management Devices Market is expected to witness market growth of 7.9% CAGR during the forecast period (2020-2026).
Pain is an unpleasant sensory and emotional experience caused by damage or disease to the tissues. It is caused by injury and a variety of diseases including osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer, fibromyalgia, and cancer. It can be classified as acute pain and chronic pain based on duration. Acute pain is a rapid occurrence of pain where it lasts for long stretches as persistent pain. Chronic pain is triggered mainly by aging bone and joint problems, including nerve damage and injuries.
Pain is managed by a particular set of pain treatment medicines or devices. The pain management systems include transcutaneous electrical nerve stimulators, neuro-stimulators, analgesic infusion pumps, and radiofrequency ablators. Most of these devices block the mechanism of the pain gate, to prevent the passage of pain signals to the brain.
Radiofrequency ablators destroy nerves by generating heat to suppress pain signals. Similarly, neuro-stimulator devices use mild current frequencies that prevent pain signals from passing in. These devices help in treating various painful conditions such as cancer, musculoskeletal injury, and neuropathic pain. Pain control tools help reduce the risk of long-term narcotics, non-steroidal anti-inflammatory medicines, and other medications that ease discomfort.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Study
Market Segmentation:
By Product
By Application
By Country
Companies Profiled
Unique Offerings from the Publisher
Pain is an unpleasant sensory and emotional experience caused by damage or disease to the tissues. It is caused by injury and a variety of diseases including osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer, fibromyalgia, and cancer. It can be classified as acute pain and chronic pain based on duration. Acute pain is a rapid occurrence of pain where it lasts for long stretches as persistent pain. Chronic pain is triggered mainly by aging bone and joint problems, including nerve damage and injuries.
Pain is managed by a particular set of pain treatment medicines or devices. The pain management systems include transcutaneous electrical nerve stimulators, neuro-stimulators, analgesic infusion pumps, and radiofrequency ablators. Most of these devices block the mechanism of the pain gate, to prevent the passage of pain signals to the brain.
Radiofrequency ablators destroy nerves by generating heat to suppress pain signals. Similarly, neuro-stimulator devices use mild current frequencies that prevent pain signals from passing in. These devices help in treating various painful conditions such as cancer, musculoskeletal injury, and neuropathic pain. Pain control tools help reduce the risk of long-term narcotics, non-steroidal anti-inflammatory medicines, and other medications that ease discomfort.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Study
Market Segmentation:
By Product
- Neuromodulation & Neurostimulation Devices
- Analgesic Infusion Pumps and
- Ablation Devices
By Application
- Neuropathic Pain
- Musculoskeletal Pain
- Cancer Pain
- Facial & Migraine Pain and
- Other Applications
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- Kimberly-Clark Corporation
- Stryker Corporation
- Colfax Corporation (DJO Global, Inc.)
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. North America Pain Management Devices Market by Product
Chapter 5. North America Pain Management Devices Market by Application
Chapter 6. North America Pain Management Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- Kimberly-Clark Corporation
- Stryker Corporation
- Colfax Corporation (DJO Global, Inc.)
Methodology
LOADING...
